arrow
S

Suryavathi Viswanadhapalli

university of texas health science center at san antonio
H指数:24
被引数:2,130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer

LIPA靶向诱导卵巢癌内质网应激和细胞死亡的治疗优化

2026-02-060
OAAI
Ligand-receptor interactions induce and mediate regulatory functions of BATF3+ B cells

配体-受体相互作用诱导并介导BATF3+ B细胞的调控功能

2025-10-080
PRE
EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling

EC359 通过抑制 LIFR 信号通路增强 Trametinib 在 Ras/Raf 驱动的卵巢癌中的疗效

2025-10-010
OAAI
Cryo-EM structures reveal the molecular mechanism of SUMO E1–E2 thioester transfer

冷冻电镜结构揭示了SUMO E1–E2硫酯转移的分子机制

2025-09-250
OAAI
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis
2024-05-243
OAAI
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (vol 3, pg 866, 2022)
2024-05-200
OAAI
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
2023-10-0110
OAAI
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma
2023-01-1813
OA
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
2022-08-118
OA
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
2022-06-0214
OAAI
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
2022-01-0118
OAAI